- Correction
- Open access
- Published:
Correction to: Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats
BMC Complementary Medicine and Therapies volume 21, Article number: 140 (2021)
The Original Article was published on 30 March 2021
Correction to: BMC Complement Med Ther 21, 104 (2021)
https://doi.org/10.1186/s12906-021-03275-5
Following publication of the original article [1], the authors reported an error in author name, affiliation, and in the Authors’ contributions statement. Authors’ contributions statement should read as below:
Authors’ contributions
This work was carried out in collaboration between all authors. TMR designed the study, performed the experiments, searched the literature, collected the data and wrote the manuscript. TM, review the data and give feedback on the article done. NG wrote the research protocol, provided the chemicals for the experiments and supervising the research work, structured the thesis and review the article. All authors read and approved the final manuscript.
The original article [1] has been updated.
Reference
Mengesha T, Gnanasekaran N, Mehare T. Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats. BMC Complement Med Ther. 2021;21:104 https://doi.org/10.1186/s12906-021-03275-5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Mengesha, T., Gnanasekaran, N. & Mehare, T. Correction to: Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats. BMC Complement Med Ther 21, 140 (2021). https://doi.org/10.1186/s12906-021-03313-2
Published:
DOI: https://doi.org/10.1186/s12906-021-03313-2